Philips presents new study results showing the benefits of their AI-powered cardiac care solutions in improving diagnosis, reducing readmissions, and lowering costs for patients…
Browsing: Adverse Events
The global pharmacovigilance market is expected to reach $15.9 billion by 2032, driven by technological advancements and increasing patient awareness and reporting. Advanced data…
The FDA published two discussion papers this week to outline the potential of artificial intelligence (AI) and machine learning (ML) in developing and producing…